Basis of Presentation and Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2020

Summary of Cash Reported in Condensed Consolidated Statements of Cash Flows

Cash as reported in the consolidated statements of cash flows includes the aggregate amounts of cash, cash equivalents and restricted cash as presented on the consolidated balance sheets. Restricted cash at June 30, 2020 and December 31, 2019 represents cash balances held as security in connection with the Company’s facility lease agreements. The following table provides a reconciliation of cash, cash equivalents and restricted cash within the consolidated balance sheets to the total shown in the consolidated statements of cash flows (in thousands):

	June 30, 2020		December 31, 2019
Cash and cash equivalents	$	659,107	$	101,436
Restricted cash included in prepaid expenses and other current assets		366		337
Restricted cash included in restricted cash and other		1,857		1,857
Total cash, cash equivalents and restricted cash shown in the consolidated statements of cash flows	$	661,330	$	103,630

MyoKardia, Inc. 10-Q